Treatment with OCA was able to induce a clear dose-dependent increase of MMP-2 and 9 activity at 96 hours, while at 144 hours, despite a clear reduction in collagen content, the treated samples showed a trend towards a reduction in MMP-2 and 9 activity compared to FFA-treated samples.
← all excerpts
Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model.
1
—
—